Busulfan followed by cyclophosphamide (BuCy2) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation (HPCT) in adult patients when the combination is considered the best available option.
Busulfan following fludarabine (FB) is indicated as conditioning treatment prior to haematopoietic progenitor cell transplantation (HPCT) in adult patients who are candidates for a reduced-intensity conditioning (RIC) regimen.
Busulfan followed by cyclophosphamide (BuCy4) or melphalan (BuMel) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation in paediatric patients.
For this indication, competent medicine agencies globally authorize below treatments:
Intravenous
3.2 - 4.8 mg per kg of body weight
From 0.8 To 1.2 mg per kg of body weight 4 time(s) per day every day for 4 day(s)
The recommended dose of busulfan is as follows:
| Actual body weight (kg) | Busulfan dose (mg/kg) |
|---|---|
| <9 | 1.0 |
| 9 to <16 | 1.2 |
| 16 to 23 | 1.1 |
| >23 to 34 | 0.95 |
| >34 | 0.8 |
followed by:
Busulfan is administered as a two-hour infusion every 6 hours over 4 consecutive days for a total of 16 doses prior to cyclophosphamide or melphalan and haematopoietic progenitor cell transplantation (HPCT).
Busulfan should be administered by intravenous infusion via central venous catheter. Busulfan should not be given by rapid intravenous, bolus or peripheral injection.
Oral
120 - 150 mg per m² of body surface area (BSA)
From 30 To 37.5 mg per m² of body surface area (BSA) 4 time(s) per day every day for 4 day(s)
The conventional dosage plan for conditioning before haemopoietic stem cell transplantation is 30 to 37.5 mg/m² every 6 hours for 4 days, starting seven days prior to transplantation. 60 mg/kg per day of cyclophosphamide is usually given for two days commencing 24 h after the final dose of Busulfan.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.